Human Exposomic Determinants of Immune Mediated Diseases
acronym:
HEDIMED
start:
2020-01-01
end:
2024-12-31
programme:
H2020 - Horisont 2020
sub-programme:
HEALTH - Tervishoid, demograafilised muutused ja heaolu
instrument:
RIA
call identifier:
H2020-SC1-2019-Single-Stage-RTD
project number:
874864
duration in months:
60
partner count:
22
abstract:
Immune-mediated diseases (IMDs) are increasing rapidly in the developed countries constituting a huge medical, economic and societal challenge. The reasons to this epidemic are not known, but exposome needs to play an important role since genetic factors
